Blindness is one of the most feared health hazards in our present society; millions of Europeans are threatened by blinding untreatable eye diseases producing costs of several billion Euros. EVI aims at devising and implementing programs and projects for new therapeutic strategies for eye diseases that are difficult or impossible to be treated presently. Its approach will incorporate the most recent scientific developments of the postgenomic area.
The European Vision Institute should be of enormous strategic importance for the future and is targeted towards more immediate policy objectives of improving the competitiveness of European Research assembling the top institutes together with partners from industry and academia. EVI integrates, conducts and supports research that helps to prevent and treat eye diseases and other disorders of vision. This research leads to sight-saving treatments, reduces visual impairment and blindness, and improves the quality of life for people of all ages.
Meeting of the European Vision Institute - Special Interest Focus Group „New Technologies for Outcome Measures in Retina and Glaucoma” in Basel, Switzerland from 08. - 09. November 2018 Read more
Call for an end to hyped claims and the dismissal of possibly crucial effects. Read more
Academics and editors need to stop pretending that software always catches recycled text and start reading more carefully. Read more
The number of women with a career in research is slowly growing in Europe. Still, they remain significantly underrepresented, and their potential not fully recognised and valued. Read more
Support must come from a place of understanding. Read more
The "Gateway to European Vision Research" is a web-based portal service for the European vision research community and major stakeholders.
An award and public recognition by any measure is a sign of inimitability - an acknowledgment that peers and professionals alike agree that a certain person excels in what they do.
Read more about the European Vision Award and the Carl Zeiss Young Investigator Award.
Ophthalmic Research - The Journal for Translational and Clinical Research is official affiliated with the European Vision Institute